Redhill Biopharma
RDHL
48 hedge funds and large institutions have $49.1M invested in Redhill Biopharma in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 15 closing their positions.
80% more call options, than puts
Call options by funds: $4.57M | Put options by funds: $2.53M
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
0% less ownership
Funds ownership: 0% → 0% (-0%)
13% less funds holding
Funds holding: 55 → 48 (-7)
37% less capital invested
Capital invested by funds: $77.4M → $49.1M (-$28.3M)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$1.01M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$442K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$400K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$380K |
| 5 |
JG
Jefferies Group
New York
|
+$276K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
II
Ibex Investors
Denver,
Colorado
|
-$8.6M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.16M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$5.1M |
| 4 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$4.16M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.01M |
RDHL Hedge Fund Activity: Q2 2021 in Review
48 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q2 2021, worth a combined $49.1M — down 37% from $77.4M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of RDHL and 8 opened new positions — a net loss of 7 holders — while 10 trimmed existing stakes and 14 added.
The largest buyer was Disciplined Growth Investors, adding an estimated $1.01M. The largest seller was Ibex Investors, cutting an estimated $8.6M.
- 48 institutional investors held Redhill Biopharma (RDHL) as of Q2 2021, down from 55 in Q1 2021.
- Funds reported $49.1M of Redhill Biopharma stock for Q2 2021, down 37% quarter-over-quarter.
- 8 funds opened new Redhill Biopharma positions in Q2 2021 and 15 closed out, a net change of -7 holders.
- The largest Redhill Biopharma buyer in Q2 2021 was Disciplined Growth Investors, an estimated $1.01M added.
- The largest Redhill Biopharma seller in Q2 2021 was Ibex Investors, an estimated $8.6M sold.
Based on aggregated 13F filings for Q2 2021.